Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
- PMID: 22798229
- DOI: 10.1007/s11684-012-0203-9
Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
Abstract
In order to find out the potential indicators predicting prognosis of malignant gastrointestinal stromal tumors (GISTs) after surgical resection, we collected clinical records of 80 patients with malignant GISTs. Tumor location, size, mitotic index, necrosis were compared with the prognosis of malignant GISTs by Kaplan-Meier method and log-rank test. After a median follow-up of 844 days (52-2 145), we found that as National Institutes of Health suggested, tumors with intermediate risk had more favorable prognosis than that with high risk. Their 3-year survival rate were 65.3% and 41.3%, respectively (P < 0.001). Moreover, tumor size and mitotic index were associated with free survival. The 3-year survival rate for patients with tumor size ≤ 10 cm and > 10 cm were 62.3% and 41.8%, respectively (P = 0.002), Tumors with mitotic index ≤ 5/50 HPF had a higher 3-year survival rate than tumors with mitotic index > 5/50 HPF (67.1% versus 40.7%, P = 0.005). The presence of necrosis was directly related to the malignant behavior. The 3-year survival rate for presence and absence necrosis were 50.8% and 64.8% (P = 0.008). From the present study, we can conclude that besides tumors size and mitotic index, tumor location and necrosis also influence on the long-term survival of patient with malignant GISTs after surgical resection.
Similar articles
-
Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.World J Gastroenterol. 2018 Jun 21;24(23):2508-2517. doi: 10.3748/wjg.v24.i23.2508. World J Gastroenterol. 2018. PMID: 29930472 Free PMC article. Clinical Trial.
-
Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.Am J Surg. 2013 Sep;206(3):360-7. doi: 10.1016/j.amjsurg.2012.11.010. Epub 2013 May 11. Am J Surg. 2013. PMID: 23673012
-
Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.Cancer. 2011 Nov 1;117(21):4916-24. doi: 10.1002/cncr.26079. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456019
-
Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.JOP. 2011 Mar 9;12(2):194-9. JOP. 2011. PMID: 21386652 Review.
-
Multivisceral resections for gastrointestinal stromal tumors: are the risks justifiable?Surg Oncol. 2015 Mar;24(1):54-9. doi: 10.1016/j.suronc.2015.01.003. Epub 2015 Feb 4. Surg Oncol. 2015. PMID: 25697716 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources